Does TEMSIROLIMUS Cause Interstitial lung disease? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Interstitial lung disease have been filed in association with TEMSIROLIMUS (Temsirolimus). This represents 1.3% of all adverse event reports for TEMSIROLIMUS.
22
Reports of Interstitial lung disease with TEMSIROLIMUS
1.3%
of all TEMSIROLIMUS reports
10
Deaths
13
Hospitalizations
How Dangerous Is Interstitial lung disease From TEMSIROLIMUS?
Of the 22 reports, 10 (45.5%) resulted in death, 13 (59.1%) required hospitalization, and 2 (9.1%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
Yes, Interstitial lung disease is listed as a known adverse reaction in the official FDA drug label for TEMSIROLIMUS.
What Other Side Effects Does TEMSIROLIMUS Cause?
Disease progression (158)
Death (136)
Stomatitis (100)
Anaemia (89)
Neoplasm progression (84)
Vomiting (81)
Diarrhoea (79)
Febrile neutropenia (78)
Pneumonia (76)
Off label use (75)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which TEMSIROLIMUS Alternatives Have Lower Interstitial lung disease Risk?
TEMSIROLIMUS vs TENAMFETAMINE
TEMSIROLIMUS vs TENAPANOR
TEMSIROLIMUS vs TENECTEPLASE
TEMSIROLIMUS vs TENELIGLIPTIN
TEMSIROLIMUS vs TENIPOSIDE